The first credible genetic case for GPR30 as a novel ER was that rapid estrogen responses can be reproduced in non-responsive breast cancer cells via transfection with a GPR30 expression vector (Filardo et al., 2002). The gene discussed is GPER1; the disease is breast cancer.